Craig Porter
Concepts (300)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Burns | 31 | 2021 | 162 | 8.870 |
Why?
| Muscle, Skeletal | 30 | 2023 | 750 | 4.250 |
Why?
| Adipose Tissue, Brown | 14 | 2022 | 40 | 4.050 |
Why?
| Mitochondria, Muscle | 9 | 2018 | 37 | 3.750 |
Why?
| Mitochondria | 15 | 2021 | 402 | 3.230 |
Why?
| Thermogenesis | 8 | 2022 | 25 | 2.920 |
Why?
| Adipose Tissue, White | 9 | 2022 | 34 | 2.720 |
Why?
| Energy Metabolism | 13 | 2023 | 282 | 2.500 |
Why?
| Muscle Proteins | 13 | 2021 | 303 | 1.450 |
Why?
| Glucose | 3 | 2023 | 344 | 1.270 |
Why?
| Exercise Therapy | 6 | 2021 | 98 | 1.080 |
Why?
| Cachexia | 4 | 2019 | 25 | 1.060 |
Why?
| Resistance Training | 7 | 2021 | 92 | 0.990 |
Why?
| Oxygen Consumption | 6 | 2018 | 183 | 0.960 |
Why?
| Muscle Fibers, Skeletal | 3 | 2019 | 62 | 0.940 |
Why?
| Physical Conditioning, Animal | 2 | 2023 | 52 | 0.930 |
Why?
| Proteomics | 2 | 2023 | 329 | 0.870 |
Why?
| Adipocytes | 2 | 2021 | 121 | 0.850 |
Why?
| Insulin Resistance | 5 | 2019 | 264 | 0.820 |
Why?
| Lipid Metabolism | 5 | 2019 | 175 | 0.820 |
Why?
| Peripheral Arterial Disease | 1 | 2023 | 66 | 0.810 |
Why?
| Muscular Atrophy | 3 | 2021 | 70 | 0.780 |
Why?
| Humans | 58 | 2024 | 49974 | 0.730 |
Why?
| Mice, Inbred BALB C | 6 | 2020 | 304 | 0.730 |
Why?
| Male | 41 | 2024 | 25241 | 0.730 |
Why?
| Cell Respiration | 6 | 2019 | 41 | 0.720 |
Why?
| Quadriceps Muscle | 4 | 2021 | 46 | 0.720 |
Why?
| Animals | 20 | 2024 | 13187 | 0.680 |
Why?
| Diabetes Mellitus | 1 | 2023 | 285 | 0.670 |
Why?
| Sepsis | 2 | 2019 | 220 | 0.660 |
Why?
| Mitochondrial Proteins | 6 | 2017 | 90 | 0.640 |
Why?
| Mitochondria, Liver | 2 | 2018 | 70 | 0.640 |
Why?
| Stress, Physiological | 2 | 2016 | 170 | 0.630 |
Why?
| Musculoskeletal Diseases | 1 | 2018 | 46 | 0.630 |
Why?
| Oxidative Phosphorylation | 2 | 2015 | 39 | 0.620 |
Why?
| Down-Regulation | 2 | 2017 | 348 | 0.590 |
Why?
| Mitochondrial Diseases | 2 | 2015 | 42 | 0.590 |
Why?
| Sex Characteristics | 1 | 2018 | 190 | 0.570 |
Why?
| Oxidative Stress | 3 | 2018 | 770 | 0.560 |
Why?
| Electron Transport Complex II | 1 | 2015 | 7 | 0.510 |
Why?
| Electron Transport Complex I | 1 | 2015 | 23 | 0.510 |
Why?
| Ion Channels | 4 | 2015 | 72 | 0.480 |
Why?
| Mice | 10 | 2022 | 5739 | 0.440 |
Why?
| Muscle Strength | 7 | 2021 | 124 | 0.440 |
Why?
| Quality of Life | 1 | 2018 | 836 | 0.420 |
Why?
| Amino Acids | 2 | 2020 | 360 | 0.420 |
Why?
| Young Adult | 10 | 2021 | 3958 | 0.390 |
Why?
| Recovery of Function | 3 | 2021 | 188 | 0.380 |
Why?
| Fungal Proteins | 3 | 2020 | 118 | 0.380 |
Why?
| Aging | 2 | 2017 | 687 | 0.380 |
Why?
| Health Status | 1 | 2013 | 298 | 0.380 |
Why?
| Female | 26 | 2024 | 26472 | 0.380 |
Why?
| Liver | 5 | 2023 | 1115 | 0.360 |
Why?
| Blood Glucose | 4 | 2017 | 439 | 0.360 |
Why?
| Adult | 13 | 2024 | 13236 | 0.350 |
Why?
| Fibroblast Growth Factors | 2 | 2021 | 47 | 0.350 |
Why?
| Inflammation | 3 | 2024 | 604 | 0.350 |
Why?
| Muscular Diseases | 2 | 2020 | 58 | 0.340 |
Why?
| Citrate (si)-Synthase | 3 | 2019 | 11 | 0.330 |
Why?
| Cold Temperature | 4 | 2017 | 44 | 0.320 |
Why?
| Basal Metabolism | 3 | 2018 | 31 | 0.310 |
Why?
| Subcutaneous Fat | 2 | 2019 | 18 | 0.310 |
Why?
| Child | 14 | 2022 | 6847 | 0.310 |
Why?
| Mice, Inbred C57BL | 3 | 2022 | 1816 | 0.300 |
Why?
| Case-Control Studies | 5 | 2017 | 1131 | 0.280 |
Why?
| Child, Preschool | 6 | 2018 | 3871 | 0.270 |
Why?
| Pregnancy in Diabetics | 2 | 2024 | 31 | 0.260 |
Why?
| Adolescent | 10 | 2018 | 6356 | 0.250 |
Why?
| Lipids | 2 | 2023 | 147 | 0.250 |
Why?
| Exercise | 5 | 2021 | 495 | 0.250 |
Why?
| Rats | 2 | 2023 | 3305 | 0.240 |
Why?
| Hypertrophy, Left Ventricular | 1 | 2024 | 39 | 0.240 |
Why?
| Body Composition | 5 | 2021 | 318 | 0.240 |
Why?
| Receptors, Purinergic | 1 | 2024 | 12 | 0.240 |
Why?
| Beverages | 2 | 2021 | 68 | 0.230 |
Why?
| Diet, High-Fat | 3 | 2021 | 222 | 0.220 |
Why?
| Limb Salvage | 1 | 2023 | 37 | 0.220 |
Why?
| Protein Biosynthesis | 3 | 2021 | 253 | 0.220 |
Why?
| Regeneration | 2 | 2020 | 72 | 0.210 |
Why?
| RNA, Messenger | 2 | 2016 | 1105 | 0.210 |
Why?
| Signal Transduction | 4 | 2024 | 1618 | 0.210 |
Why?
| Ischemia | 1 | 2023 | 153 | 0.200 |
Why?
| Trauma Severity Indices | 2 | 2019 | 47 | 0.200 |
Why?
| Cardiomyopathy, Hypertrophic | 1 | 2022 | 31 | 0.200 |
Why?
| Blood Platelets | 1 | 2024 | 245 | 0.200 |
Why?
| Proteolysis | 2 | 2019 | 94 | 0.200 |
Why?
| Time Factors | 4 | 2017 | 2903 | 0.200 |
Why?
| Diabetes, Gestational | 1 | 2022 | 53 | 0.190 |
Why?
| Gene Transfer Techniques | 1 | 2021 | 37 | 0.190 |
Why?
| Body Mass Index | 4 | 2018 | 652 | 0.190 |
Why?
| Renal Insufficiency, Chronic | 1 | 2024 | 169 | 0.190 |
Why?
| Obesity | 4 | 2021 | 1113 | 0.190 |
Why?
| Catecholamines | 1 | 2021 | 46 | 0.190 |
Why?
| Bed Rest | 1 | 2021 | 36 | 0.190 |
Why?
| Oxandrolone | 2 | 2018 | 10 | 0.190 |
Why?
| Apoptosis | 2 | 2016 | 1101 | 0.180 |
Why?
| Adiposity | 3 | 2019 | 127 | 0.180 |
Why?
| Carnitine | 2 | 2019 | 62 | 0.180 |
Why?
| Hepatocytes | 2 | 2019 | 182 | 0.180 |
Why?
| Propranolol | 2 | 2018 | 78 | 0.180 |
Why?
| Phenylalanine | 1 | 2020 | 128 | 0.180 |
Why?
| Myofibrils | 2 | 2020 | 19 | 0.180 |
Why?
| Milk Proteins | 1 | 2020 | 78 | 0.170 |
Why?
| Prospective Studies | 4 | 2018 | 2364 | 0.170 |
Why?
| Capillaries | 1 | 2019 | 50 | 0.170 |
Why?
| Metformin | 2 | 2017 | 64 | 0.170 |
Why?
| Leukocytes, Mononuclear | 1 | 2019 | 116 | 0.170 |
Why?
| Gonads | 1 | 2019 | 4 | 0.170 |
Why?
| Receptors, Aryl Hydrocarbon | 1 | 2019 | 25 | 0.170 |
Why?
| Adaptation, Physiological | 1 | 2019 | 91 | 0.170 |
Why?
| GTPase-Activating Proteins | 1 | 2019 | 23 | 0.160 |
Why?
| Middle Aged | 8 | 2019 | 12069 | 0.160 |
Why?
| Adrenergic beta-Antagonists | 2 | 2021 | 102 | 0.160 |
Why?
| Up-Regulation | 2 | 2017 | 452 | 0.160 |
Why?
| Infant, Newborn | 3 | 2024 | 2772 | 0.160 |
Why?
| Sarcopenia | 1 | 2019 | 84 | 0.160 |
Why?
| Electron Transport | 1 | 2018 | 25 | 0.160 |
Why?
| Hep G2 Cells | 1 | 2018 | 36 | 0.160 |
Why?
| Weight Gain | 1 | 2019 | 240 | 0.150 |
Why?
| Superoxides | 1 | 2018 | 46 | 0.150 |
Why?
| Immunologic Memory | 1 | 2017 | 30 | 0.150 |
Why?
| National Institute of General Medical Sciences (U.S.) | 1 | 2017 | 1 | 0.150 |
Why?
| Cystathionine beta-Synthase | 1 | 2017 | 17 | 0.150 |
Why?
| Adenomatous Polyps | 1 | 2017 | 8 | 0.150 |
Why?
| T-Lymphocyte Subsets | 1 | 2017 | 39 | 0.150 |
Why?
| Chagas Disease | 1 | 2017 | 3 | 0.150 |
Why?
| Blotting, Western | 2 | 2016 | 601 | 0.150 |
Why?
| Appetite Regulation | 1 | 2017 | 12 | 0.150 |
Why?
| Burns, Electric | 1 | 2017 | 2 | 0.150 |
Why?
| Neuropeptides | 1 | 2017 | 37 | 0.150 |
Why?
| Triglycerides | 1 | 2018 | 159 | 0.150 |
Why?
| Multiple Organ Failure | 1 | 2017 | 47 | 0.150 |
Why?
| Aged | 7 | 2021 | 9310 | 0.150 |
Why?
| Physical Endurance | 1 | 2017 | 30 | 0.150 |
Why?
| Membrane Potential, Mitochondrial | 1 | 2017 | 38 | 0.150 |
Why?
| Adipocytes, Brown | 1 | 2017 | 9 | 0.150 |
Why?
| Research Support as Topic | 1 | 2017 | 46 | 0.150 |
Why?
| NF-E2-Related Factor 2 | 1 | 2017 | 41 | 0.140 |
Why?
| Fatty Acids | 1 | 2017 | 146 | 0.140 |
Why?
| Colon | 1 | 2017 | 98 | 0.140 |
Why?
| Palmitoylcarnitine | 1 | 2016 | 6 | 0.140 |
Why?
| Chronic Disease | 2 | 2017 | 567 | 0.140 |
Why?
| Blood Cells | 1 | 2016 | 43 | 0.140 |
Why?
| Mice, Knockout | 4 | 2021 | 841 | 0.140 |
Why?
| Ventricular Dysfunction, Left | 1 | 2017 | 91 | 0.140 |
Why?
| Gastrointestinal Tract | 1 | 2017 | 103 | 0.140 |
Why?
| Cardiomyopathies | 1 | 2017 | 108 | 0.130 |
Why?
| Satellite Cells, Skeletal Muscle | 1 | 2016 | 24 | 0.130 |
Why?
| Intestinal Mucosa | 1 | 2017 | 225 | 0.130 |
Why?
| Trauma Centers | 1 | 2017 | 193 | 0.130 |
Why?
| Infant | 3 | 2022 | 3567 | 0.130 |
Why?
| Electron Transport Chain Complex Proteins | 1 | 2015 | 9 | 0.130 |
Why?
| Neck | 1 | 2016 | 99 | 0.130 |
Why?
| Physical Education and Training | 1 | 2015 | 24 | 0.130 |
Why?
| Proton Ionophores | 1 | 2015 | 3 | 0.130 |
Why?
| Uncoupling Agents | 1 | 2015 | 5 | 0.130 |
Why?
| Carbonyl Cyanide m-Chlorophenyl Hydrazone | 1 | 2015 | 5 | 0.130 |
Why?
| Oligomycins | 1 | 2015 | 7 | 0.130 |
Why?
| Adipose Tissue | 1 | 2017 | 187 | 0.130 |
Why?
| Reactive Oxygen Species | 1 | 2017 | 408 | 0.130 |
Why?
| Severity of Illness Index | 2 | 2018 | 945 | 0.130 |
Why?
| DNA, Mitochondrial | 1 | 2015 | 112 | 0.120 |
Why?
| Acute Disease | 1 | 2015 | 366 | 0.120 |
Why?
| Cardiovascular System | 1 | 2015 | 49 | 0.120 |
Why?
| Anabolic Agents | 1 | 2014 | 33 | 0.120 |
Why?
| Risk Factors | 1 | 2023 | 3613 | 0.120 |
Why?
| Insulin | 4 | 2019 | 457 | 0.120 |
Why?
| Androgens | 1 | 2014 | 69 | 0.120 |
Why?
| Lung | 2 | 2015 | 486 | 0.120 |
Why?
| Treatment Outcome | 2 | 2023 | 5141 | 0.120 |
Why?
| Biomedical Research | 1 | 2017 | 237 | 0.120 |
Why?
| Rest | 1 | 2014 | 63 | 0.120 |
Why?
| Rats, Sprague-Dawley | 1 | 2018 | 1597 | 0.120 |
Why?
| Overweight | 1 | 2016 | 219 | 0.120 |
Why?
| Cohort Studies | 2 | 2015 | 1422 | 0.120 |
Why?
| Hypoglycemic Agents | 1 | 2014 | 168 | 0.110 |
Why?
| Infusions, Intravenous | 1 | 2013 | 206 | 0.110 |
Why?
| Metabolic Diseases | 1 | 2013 | 40 | 0.110 |
Why?
| Biopsy | 1 | 2014 | 584 | 0.100 |
Why?
| Fluorodeoxyglucose F18 | 3 | 2017 | 192 | 0.090 |
Why?
| Double-Blind Method | 2 | 2020 | 681 | 0.080 |
Why?
| Dietary Proteins | 2 | 2021 | 242 | 0.080 |
Why?
| Body Weight | 2 | 2021 | 513 | 0.080 |
Why?
| Aged, 80 and over | 1 | 2015 | 3129 | 0.080 |
Why?
| Torque | 2 | 2018 | 18 | 0.070 |
Why?
| Mice, Transgenic | 2 | 2019 | 555 | 0.070 |
Why?
| Mitochondria, Heart | 2 | 2017 | 35 | 0.070 |
Why?
| Gene Expression | 2 | 2020 | 609 | 0.070 |
Why?
| Homeostasis | 2 | 2019 | 200 | 0.070 |
Why?
| Kinetics | 2 | 2018 | 623 | 0.070 |
Why?
| Pregnancy | 2 | 2024 | 2607 | 0.070 |
Why?
| Body Surface Area | 2 | 2016 | 24 | 0.070 |
Why?
| Retrospective Studies | 3 | 2024 | 6108 | 0.070 |
Why?
| Exercise Test | 2 | 2017 | 121 | 0.060 |
Why?
| Nutritional Support | 2 | 2015 | 34 | 0.060 |
Why?
| Oxidation-Reduction | 2 | 2016 | 322 | 0.060 |
Why?
| Radiopharmaceuticals | 2 | 2017 | 209 | 0.060 |
Why?
| Phenotype | 2 | 2019 | 729 | 0.060 |
Why?
| Purinergic Antagonists | 1 | 2024 | 7 | 0.060 |
Why?
| Gene Expression Regulation | 2 | 2020 | 976 | 0.060 |
Why?
| Positron-Emission Tomography | 2 | 2017 | 295 | 0.060 |
Why?
| Hemostasis | 1 | 2024 | 55 | 0.060 |
Why?
| Disease Models, Animal | 2 | 2017 | 1455 | 0.050 |
Why?
| Thrombosis | 1 | 2024 | 248 | 0.050 |
Why?
| Respiration | 1 | 2021 | 97 | 0.050 |
Why?
| Polyphenols | 1 | 2021 | 52 | 0.050 |
Why?
| Muscle Contraction | 1 | 2021 | 105 | 0.050 |
Why?
| Leucine | 1 | 2021 | 116 | 0.050 |
Why?
| Tomography, X-Ray Computed | 2 | 2017 | 1159 | 0.040 |
Why?
| Nutritional Physiological Phenomena | 1 | 2019 | 22 | 0.040 |
Why?
| Body Temperature Regulation | 1 | 2019 | 24 | 0.040 |
Why?
| Hypertrophy | 1 | 2019 | 50 | 0.040 |
Why?
| NF-kappa B | 1 | 2021 | 314 | 0.040 |
Why?
| Mothers | 1 | 2022 | 249 | 0.040 |
Why?
| Drinking | 1 | 2019 | 38 | 0.040 |
Why?
| Rabbits | 1 | 2019 | 370 | 0.040 |
Why?
| Ubiquitin-Protein Ligases | 1 | 2019 | 92 | 0.040 |
Why?
| Tamoxifen | 1 | 2019 | 60 | 0.040 |
Why?
| Autophagy | 1 | 2019 | 169 | 0.040 |
Why?
| HEK293 Cells | 1 | 2019 | 222 | 0.040 |
Why?
| Athletic Injuries | 1 | 2020 | 191 | 0.040 |
Why?
| Acetyl-CoA Carboxylase | 1 | 2017 | 13 | 0.040 |
Why?
| Artifacts | 1 | 2018 | 53 | 0.040 |
Why?
| Host-Parasite Interactions | 1 | 2017 | 16 | 0.040 |
Why?
| Adoptive Transfer | 1 | 2017 | 40 | 0.040 |
Why?
| Hydrogen Sulfide | 1 | 2017 | 5 | 0.040 |
Why?
| HCT116 Cells | 1 | 2017 | 22 | 0.040 |
Why?
| Exercise Tolerance | 1 | 2017 | 36 | 0.040 |
Why?
| Antioxidant Response Elements | 1 | 2017 | 3 | 0.040 |
Why?
| Gastric Inhibitory Polypeptide | 1 | 2017 | 2 | 0.040 |
Why?
| Glucagon | 1 | 2017 | 22 | 0.040 |
Why?
| Transplantation, Heterologous | 1 | 2017 | 74 | 0.040 |
Why?
| Transcription, Genetic | 1 | 2019 | 369 | 0.040 |
Why?
| History, 21st Century | 1 | 2017 | 56 | 0.040 |
Why?
| Malaria | 1 | 2017 | 37 | 0.040 |
Why?
| Ghrelin | 1 | 2017 | 30 | 0.040 |
Why?
| Feeding Behavior | 1 | 2019 | 181 | 0.040 |
Why?
| History, 20th Century | 1 | 2017 | 99 | 0.040 |
Why?
| Lymphocyte Activation | 1 | 2017 | 172 | 0.040 |
Why?
| Protein Binding | 1 | 2019 | 660 | 0.040 |
Why?
| Mice, Nude | 1 | 2017 | 252 | 0.040 |
Why?
| Superoxide Dismutase | 1 | 2017 | 113 | 0.040 |
Why?
| Child, Hospitalized | 1 | 2017 | 30 | 0.040 |
Why?
| Drug Administration Schedule | 1 | 2017 | 376 | 0.040 |
Why?
| HeLa Cells | 1 | 2017 | 250 | 0.040 |
Why?
| ATP-Dependent Proteases | 1 | 2016 | 1 | 0.040 |
Why?
| Endopeptidase Clp | 1 | 2016 | 1 | 0.040 |
Why?
| PAX7 Transcription Factor | 1 | 2016 | 10 | 0.030 |
Why?
| Mitochondrial Membrane Transport Proteins | 1 | 2016 | 18 | 0.030 |
Why?
| MyoD Protein | 1 | 2016 | 10 | 0.030 |
Why?
| Palmitates | 1 | 2016 | 29 | 0.030 |
Why?
| Myosin Heavy Chains | 1 | 2016 | 20 | 0.030 |
Why?
| Metabolism | 1 | 2016 | 25 | 0.030 |
Why?
| Promoter Regions, Genetic | 1 | 2019 | 475 | 0.030 |
Why?
| Hyperinsulinism | 1 | 2016 | 26 | 0.030 |
Why?
| Heart Rate | 1 | 2018 | 293 | 0.030 |
Why?
| Metabolomics | 1 | 2017 | 126 | 0.030 |
Why?
| Cell Movement | 1 | 2017 | 247 | 0.030 |
Why?
| Multiprotein Complexes | 1 | 2016 | 23 | 0.030 |
Why?
| Caspase 3 | 1 | 2016 | 97 | 0.030 |
Why?
| Lipoproteins | 1 | 2016 | 39 | 0.030 |
Why?
| CD4-Positive T-Lymphocytes | 1 | 2017 | 164 | 0.030 |
Why?
| Leptin | 1 | 2017 | 140 | 0.030 |
Why?
| Peroxidase | 1 | 2015 | 15 | 0.030 |
Why?
| TOR Serine-Threonine Kinases | 1 | 2016 | 77 | 0.030 |
Why?
| Microscopy, Electron | 1 | 2016 | 77 | 0.030 |
Why?
| Fluorescent Antibody Technique | 1 | 2016 | 108 | 0.030 |
Why?
| Neutrophil Infiltration | 1 | 2015 | 26 | 0.030 |
Why?
| Sex Factors | 1 | 2018 | 691 | 0.030 |
Why?
| Cell Survival | 1 | 2017 | 600 | 0.030 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 181 | 0.030 |
Why?
| Lipid Peroxidation | 1 | 2015 | 100 | 0.030 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2016 | 114 | 0.030 |
Why?
| Linear Models | 1 | 2016 | 280 | 0.030 |
Why?
| Antioxidants | 1 | 2017 | 249 | 0.030 |
Why?
| Cells, Cultured | 1 | 2019 | 1573 | 0.030 |
Why?
| Muscle Strength Dynamometer | 1 | 2014 | 12 | 0.030 |
Why?
| Glucose Clamp Technique | 1 | 2014 | 15 | 0.030 |
Why?
| Cell Line | 1 | 2017 | 1000 | 0.030 |
Why?
| Calorimetry, Indirect | 1 | 2014 | 25 | 0.030 |
Why?
| Survivors | 1 | 2015 | 126 | 0.030 |
Why?
| Multivariate Analysis | 1 | 2016 | 577 | 0.030 |
Why?
| Collagen | 1 | 2016 | 206 | 0.030 |
Why?
| Human Growth Hormone | 1 | 2014 | 50 | 0.030 |
Why?
| Testosterone | 1 | 2014 | 139 | 0.030 |
Why?
| Organ Size | 1 | 2014 | 226 | 0.030 |
Why?
| Absorptiometry, Photon | 1 | 2014 | 154 | 0.030 |
Why?
| DNA Damage | 1 | 2015 | 301 | 0.030 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 828 | 0.030 |
Why?
| Recombinant Proteins | 1 | 2014 | 486 | 0.030 |
Why?
| Immunohistochemistry | 1 | 2016 | 973 | 0.030 |
Why?
| Macrophages | 1 | 2015 | 363 | 0.030 |
Why?
| Ambulatory Care | 1 | 2014 | 222 | 0.030 |
Why?
| Myocardium | 1 | 2015 | 436 | 0.030 |
Why?
| Cytokines | 1 | 2016 | 612 | 0.030 |
Why?
| Gene Expression Profiling | 1 | 2017 | 1032 | 0.030 |
Why?
| Predictive Value of Tests | 1 | 2015 | 903 | 0.030 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2016 | 477 | 0.020 |
Why?
| Follow-Up Studies | 1 | 2015 | 2182 | 0.020 |
Why?
| United States | 1 | 2017 | 4860 | 0.020 |
Why?
|
|
Porter's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|